Literature DB >> 11063129

Cell cycle checkpoints and their inactivation in human cancer.

M Molinari1.   

Abstract

Checkpoints are mechanisms that regulate progression through the cell cycle insuring that each step takes place only once and in the right sequence. Mutations of checkpoint proteins are frequent in all types of cancer as defects in cell cycle control can lead to genetic instability. This review will focus on three major areas of cell cycle transition control, with particular attention to the alterations found in human cancer. These areas include the G1/S transition, where most cancer-related defects occur, the G2/M checkpoint and its activation in response to DNA damage, and the spindle checkpoint.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11063129      PMCID: PMC6496592          DOI: 10.1046/j.1365-2184.2000.00191.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  129 in total

1.  Cell cycle: will the real Cdk-activating kinase please stand up.

Authors:  G F Draetta
Journal:  Curr Biol       Date:  1997-01-01       Impact factor: 10.834

2.  Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.

Authors:  D W Bell; J M Varley; T E Szydlo; D H Kang; D C Wahrer; K E Shannon; M Lubratovich; S J Verselis; K J Isselbacher; J F Fraumeni; J M Birch; F P Li; J E Garber; D A Haber
Journal:  Science       Date:  1999-12-24       Impact factor: 47.728

3.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.

Authors:  L A Donehower; M Harvey; B L Slagle; M J McArthur; C A Montgomery; J S Butel; A Bradley
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

4.  A p53-dependent mouse spindle checkpoint.

Authors:  S M Cross; C A Sanchez; C A Morgan; M K Schimke; S Ramel; R L Idzerda; W H Raskind; B J Reid
Journal:  Science       Date:  1995-03-03       Impact factor: 47.728

5.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Authors:  D Malkin; F P Li; L C Strong; J F Fraumeni; C E Nelson; D H Kim; J Kassel; M A Gryka; F Z Bischoff; M A Tainsky
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

6.  The checkpoint protein MAD2 and the mitotic regulator CDC20 form a ternary complex with the anaphase-promoting complex to control anaphase initiation.

Authors:  G Fang; H Yu; M W Kirschner
Journal:  Genes Dev       Date:  1998-06-15       Impact factor: 11.361

7.  MPF localization is controlled by nuclear export.

Authors:  A Hagting; C Karlsson; P Clute; M Jackman; J Pines
Journal:  EMBO J       Date:  1998-07-15       Impact factor: 11.598

8.  Phosphorylation and activation of the Xenopus Cdc25 phosphatase in the absence of Cdc2 and Cdk2 kinase activity.

Authors:  T Izumi; J L Maller
Journal:  Mol Biol Cell       Date:  1995-02       Impact factor: 4.138

9.  Mutations of p34cdc2 phosphorylation sites induce premature mitotic events in HeLa cells: evidence for a double block to p34cdc2 kinase activation in vertebrates.

Authors:  W Krek; E A Nigg
Journal:  EMBO J       Date:  1991-11       Impact factor: 11.598

10.  Mammalian p55CDC mediates association of the spindle checkpoint protein Mad2 with the cyclosome/anaphase-promoting complex, and is involved in regulating anaphase onset and late mitotic events.

Authors:  M Kallio; J Weinstein; J R Daum; D J Burke; G J Gorbsky
Journal:  J Cell Biol       Date:  1998-06-15       Impact factor: 10.539

View more
  97 in total

1.  Chk2-mediated G2/M cell cycle arrest maintains radiation resistance in malignant meningioma cells.

Authors:  Venkateswara Rao Gogineni; Arun Kumar Nalla; Reshu Gupta; Dzung H Dinh; Jeffrey D Klopfenstein; Jasti S Rao
Journal:  Cancer Lett       Date:  2011-09-06       Impact factor: 8.679

2.  Activation of checkpoint kinase 2 by 3,3'-diindolylmethane is required for causing G2/M cell cycle arrest in human ovarian cancer cells.

Authors:  Prabodh K Kandala; Sanjay K Srivastava
Journal:  Mol Pharmacol       Date:  2010-05-05       Impact factor: 4.436

3.  Fbxw8 is involved in the proliferation of human choriocarcinoma JEG-3 cells.

Authors:  Ping Lin; Jiejun Fu; Binjiahui Zhao; Feng Lin; Haifeng Zou; Leiyu Liu; Cheng Zhu; Hongmei Wang; Xiaoguang Yu
Journal:  Mol Biol Rep       Date:  2010-09-29       Impact factor: 2.316

4.  Segment- and cell-specific expression of D-type cyclins in the postnatal mouse epididymis.

Authors:  Huizhen Wang; T Rajendra Kumar
Journal:  Gene Expr Patterns       Date:  2012-01-24       Impact factor: 1.224

5.  Less efficient g2-m checkpoint is associated with an increased risk of lung cancer in African Americans.

Authors:  Yun-Ling Zheng; Christopher A Loffredo; Anthony J Alberg; Zhipeng Yu; Raymond T Jones; Donna Perlmutter; Lindsey Enewold; Mark J Krasna; Rex Yung; Peter G Shields; Curtis C Harris
Journal:  Cancer Res       Date:  2005-10-15       Impact factor: 12.701

6.  Varying responses of human cells with discrepant p53 activity to ionizing radiation and heat shock exposure.

Authors:  S V Tokalov; S Pieck; H O Gutzeit
Journal:  Cell Prolif       Date:  2007-02       Impact factor: 6.831

7.  Modeling Therapy Resistance in BRCA1/2-Mutant Cancers.

Authors:  Amy Dréan; Chris T Williamson; Rachel Brough; Inger Brandsma; Malini Menon; Asha Konde; Isaac Garcia-Murillas; Helen N Pemberton; Jessica Frankum; Rumana Rafiq; Nicholas Badham; James Campbell; Aditi Gulati; Nicholas C Turner; Stephen J Pettitt; Alan Ashworth; Christopher J Lord
Journal:  Mol Cancer Ther       Date:  2017-06-15       Impact factor: 6.261

8.  Oxygen-Glucose Deprivation Induces G2/M Cell Cycle Arrest in Brain Pericytes Associated with ERK Inactivation.

Authors:  Wenjie Wei; Zhiyuan Yu; Minjie Xie; Wei Wang; Xiang Luo
Journal:  J Mol Neurosci       Date:  2016-09-24       Impact factor: 3.444

9.  Borealin is repressed in response to p53/Rb signaling.

Authors:  Dipali A Date; Cara J Jacob; Mike E Bekier; Andrew C Stiff; Mark W Jackson; William R Taylor
Journal:  Cell Biol Int       Date:  2007-07-15       Impact factor: 3.612

10.  Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo.

Authors:  Tripti Singh; Ram Prasad; Santosh K Katiyar
Journal:  Epigenetics       Date:  2012-12-05       Impact factor: 4.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.